
Keywords: LLNA; local lymph node assay; ECVAM; European centre for the validation of alternative methods; DPRA; direct peptide reactivity assay; HTS-DCYA; high-throughput dansyl-cysteamine; DABS-C1; 4-(4-dimethylaminophenylazo) benzenesulfonyl chloride; ROC; receiv